PPD (PPD) Current Deferred Taxes Liabilities : $0 Mil (As of Sep. 2021)

View and export this data going back to 2020. Start your Free Trial

What is PPD Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

PPD's current deferred tax liabilities for the quarter that ended in Sep. 2021 was $0 Mil.

PPD Current Deferred Taxes Liabilities Historical Data

The historical data trend for PPD's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PPD Current Deferred Taxes Liabilities Chart

PPD Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Current Deferred Taxes Liabilities

PPD Quarterly Data
	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial									-	-	-	-	-

PPD Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of PPD's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

PPD (PPD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PPD Inc (NAS:PPD) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

929 North Front Street, Wilmington, NC, USA, 28401

Website

https://www.ppdi.com

PPD is a global contract research organization that provides clinical trial and laboratory services to pharmaceutical, device, and diagnostic firms. The clinical development services segment offers outsourced trial services, spanning early- and late-stage trials, as well as peri- and post-approval trials, and the laboratory services segment includes both advanced lab testing and central lab services. The company was taken private in 2011 and went public again in 2020.. Thermo Fisher Scientific announced it will acquire PPD for $17.4 billion, which is scheduled to close by the end of 2021.

Executives

H&f Corporate Investors Viii, Ltd.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
H&f Corporate Investors Vii, Ltd.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
David Michael Johnston	officer: See Remarks	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
David S Simmons	director, officer: Chief Executive Officer	PFIZER INC. ATTN. CORP. SECRETARY, 235 EAST 42ND STREET, NEW YORK NY 10017
Glen Donovan	officer: Chief Accounting Officer	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
Ronald E Garrow	officer: See Remarks	2000 PURCHASE STREET, PURCHASE NY 10577
Karen Kaucic	officer: See Remarks	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
Judd Hartman	officer: See Remarks	3124 DEVER COURT WILMINGTON NC 28411
Jill Pellegrino	officer: SVP & General Manager of AES	C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401
H&f Executives Vii, L.p.	10 percent owner	ONE MARITIME PLAZA 12TH FLOOR SAN FRANCISCO CA 94111
Hellman & Friedman Investors Viii, L.p.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
P. Hunter Philbrick	director	C/O HELLMAN & FRIEDMAN INVESTORS, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Carlyle Partners Vi Holdings Ii, L.p.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH 1001 PENNSYLVANIA AVENUE, N.W. WASHINGTON DC 20004
Tc Group Vi, L.l.c.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA ANVENE, N.W., WASHINGTON DC 20004
Tc Group Vi, L.p.	10 percent owner	C/O THE CARLYLE GROUP, SUITE 220 SOUTH, 1001 PENNSYLVANIA AVENUE, N.W., WASHINGTON DC 20004